Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Aug 27, 2023; 15(8): 1629-1640
Published online Aug 27, 2023. doi: 10.4240/wjgs.v15.i8.1629
Published online Aug 27, 2023. doi: 10.4240/wjgs.v15.i8.1629
Table 1 Characteristics of patients undergoing endoscopic submucosal dissection and laparoscopic surgery
ESD with/without backup surgery (n = 100) | Laparoscopic surgery (n = 94) | OR (95%CI) | P value | |
Age, yr, median (range) | 56 (49-62) | 62 (52-70) | 1.04 (1.02-1.07) | 0.001a |
Male gender, n (%) | 46 (46) | 47 (50) | 1.17 (0.67-2.06) | 0.577 |
Tumor size, n (%) | ||||
≤ 2 cm | 72 (72) | 15 (16) | 1 | |
3-5 cm | 26 (26) | 54 (57.4) | 9.97 (4.82-20.62) | < 0.001a |
> 5 cm | 2 (2) | 25 (26.6) | 60 (12.81-281) | < 0.001a |
Tumor location, n (%) | ||||
Upper | 81 (81) | 61 (64.9) | 1 | |
Middle | 6 (6) | 14 (14.9) | 3.1 (1.13-8.53) | 0.029a |
Low | 13 (13) | 19 (20.2) | 1.94 (0.89-4.23) | 0.096 |
Layer of tumor origin, n (%) | ||||
Submucosa | 6 (6) | 3 (3.2) | 1 | |
Muscularis propria | 94 (94) | 91 (96.8) | 1.94 (0.47-7.97) | 0.36 |
Exophytic growth, n (%) | 11 (11) | 53 (56.4) | 10.46 (4.95-22.08) | < 0.001a |
Pathology, n (%) | ||||
Benign | 55 (55) | 14 (14.9) | 1 | |
Malignant or malignant potential | 45 (45) | 80 (85.1) | 6.98 (3.5-13.94) | < 0.001a |
Procedure time, min, median (IQR) | 75 (40-138) | 130 (100-169) | - | < 0.001a |
Length of stay, d, median (IQR) | 5 (4-7) | 6 (4-6) | - | 0.923 |
Clavien ≥ III complication, n (%) | 5 (5) | 3 (3.2) | - | 0.527 |
Table 2 Characteristics of endoscopic submucosal dissection with backup surgery and laparoscopic surgery
ESD with backup surgery (n = 27) | Laparoscopic surgery (n = 94) | OR (95%CI) | P value | |
Age, yr, median (range) | 56 (50-64) | 62 (52-70) | 1.03 (1.00-1.06) | 0.053 |
Male gender, n (%) | 9 (33.3) | 47 (50) | 2.00 (0.82-4.90) | 0.13 |
Tumor size, n (%) | ||||
≤ 2 cm | 16 (59.3) | 15 (16) | 1 | |
3-5 cm | 11 (40.7) | 54 (57.4) | 7.66 (2.98-19.72) | < 0.001a |
> 5 cm | 0 (0) | 25 (26.6) | ||
Tumor location, n (%) | ||||
Upper | 23 (85.2) | 61 (64.9) | 1 | |
Middle | 1 (3.7) | 14 (14.9) | 3.11 (0.99-9.76) | 0.052 |
Low | 3 (11.1) | 19 (3.2) | ||
Layer of tumor origin, n (%) | ||||
Submucosa | 0 (0) | 3 (3.2) | - | 1 |
Muscularis propria | 27 (100) | 91 (96.8) | - | |
Exophytic growth, n (%) | 10 (37) | 53 (56.4) | 2.20 (0.91-5.3) | 0.08 |
Pathology, n (%) | ||||
Benign | 11 (40.7) | 14 (14.9) | 1 | |
Malignant or malignant potential | 16 (59.3) | 80 (85.1) | 3.93 (1.51-10.21) | 0.005a |
Procedure time, min, median (IQR) | 185 (150-245) | 130 (100-169) | - | < 0.001a |
Length of stay, d, median (IQR) | 7 (7-8) | 6 (4-6) | - | < 0.001a |
Clavien ≥ III complication, n (%) | 0 (0) | 3 (3.2) | - | 0.347 |
Table 3 Factors affecting procedure time and length of stay in endoscopic submucosal dissection with backup surgery and laparoscopic surgery
Factors | Without matched data | Propensity score matching | ||||
Adjusted mean difference | SE | P value | Adjusted mean difference | SE | P value | |
Procedure time | ||||||
Surgery type | ||||||
ESD with backup surgery | Reference | Reference | ||||
Laparoscopic surgery | -63.42 | 14.70 | < 0.001a | -56.40 | 18.60 | 0.005a |
Age | -0.43 | 0.42 | 0.304 | - | - | - |
Tumor size 2 | 22.04 | 13.35 | 0.101 | - | - | - |
Tumor location: middle or low | 33.58 | 12.54 | 0.008a | - | - | - |
Exophytic growth | -4.54 | 10.98 | 0.680 | - | - | - |
Pathology with malignancy | -13.81 | 15.59 | 0.378 | - | - | - |
Length of stay | ||||||
Surgery type | ||||||
ESD with backup surgery | ||||||
Laparoscopic surgery | -1.215 | 1.089 | 0.267 | -2.00 | 0.516 | 0.001a |
Age | 0.081 | 0.031a | 0.009a | - | - | - |
Tumor size 2 | -0.348 | 0.988 | 0.726 | - | - | - |
Tumor location: middle or low | 0.457 | 0.928 | 0.624 | - | - | - |
Exophytic growth | -0.218 | 0.813 | 0.789 | - | - | - |
Pathology with malignancy | -0.268 | 1.154 | 0.817 | - | - | - |
Table 4 Malignant pathology and clinical outcomes after endoscopic submucosal dissection and laparoscopic surgery
ESD with/without backup surgery (n = 100) | Laparoscopic surgery (n = 94) | P value | |
Malignant pathology in the group, n (%) | 45 (45) | 80 (85.1) | < 0.001a |
Malignant pathology | |||
GIST, n (%) | 43 (43) | 78 (83.1) | < 0.001a |
High risk | 0 (0) | 11 (14.1) | 0.001a |
Intermediate risk | 5 (11.6) | 20 (25.6) | 0.002a |
Low risk | 12 (27.9) | 36 (46.2) | < 0.001a |
Very low risk | 26 (60.5) | 11 (14.1) | 0.019a |
Neuroendocrine tumor, n (%) | 1 (1) | 1 (1) | 1.000 |
Lipoleiomyosarcoma, n (%) | 0 | 1 (1) | 0.485 |
Recurrence, n (%) | 0 | 6 (6.4) | 0.012a |
Disease related mortality, n (%) | 0 | 2 (2.1) | 0.233 |
- Citation: Chang WJ, Tsao LC, Yen HH, Yang CW, Chang HC, Kor CT, Wu SC, Lin KH. Goldilocks principle of minimally invasive surgery for gastric subepithelial tumors. World J Gastrointest Surg 2023; 15(8): 1629-1640
- URL: https://www.wjgnet.com/1948-9366/full/v15/i8/1629.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i8.1629